231 related articles for article (PubMed ID: 12911555)
1. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery.
Winkelmayer WC; Glynn RJ; Levin R; Avorn J
Kidney Int; 2003 Sep; 64(3):1046-9. PubMed ID: 12911555
[TBL] [Abstract][Full Text] [Related]
2. Infusion of 7.2% NaCl/6% hydroxyethyl starch 200/0.5 in on-pump coronary artery bypass surgery patients: a randomized, single-blind pilot study.
Lomivorotov VV; Fominskiy EV; Efremov SM; Nepomniashchikh VA; Lomivorotov VN; Chernyavskiy AM; Shilova AN; Karaskov AM
Shock; 2014 Mar; 41(3):193-9. PubMed ID: 24549094
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
[TBL] [Abstract][Full Text] [Related]
4. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
Trials; 2015 Aug; 16():384. PubMed ID: 26314293
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery.
Winkelmayer WC; Levin R; Avorn J
Am J Kidney Dis; 2003 Jan; 41(1):84-9. PubMed ID: 12500224
[TBL] [Abstract][Full Text] [Related]
7. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
Ooi JS; Ramzisham AR; Zamrin MD
Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
[TBL] [Abstract][Full Text] [Related]
8. Hetastarch and bleeding complications after coronary artery surgery.
Avorn J; Patel M; Levin R; Winkelmayer WC
Chest; 2003 Oct; 124(4):1437-42. PubMed ID: 14555577
[TBL] [Abstract][Full Text] [Related]
9. The role of hydroxyethyl starch in preventing surgical-site infections and nipple necrosis in patients undergoing reduction mammaplasty: a prospective case-control study of 334 patients.
Dieterich M; Reimer T; Kundt G; Stubert J; Gerber B
Aesthetic Plast Surg; 2013 Jun; 37(3):554-60. PubMed ID: 23571784
[TBL] [Abstract][Full Text] [Related]
10. Priming and replenishment in cardiopulmonary bypass with hydroxyethyl starch 130/0.4 decreases fluid overbalance without renal dysfunction or bleeding in adult valve surgery.
Isoda S; Izubuchi R; Yamazaki I; Nakayama Y; Yano Y; Masuda M
Gen Thorac Cardiovasc Surg; 2019 Apr; 67(4):374-376. PubMed ID: 30805825
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study.
Gurbuz HA; Durukan AB; Salman N; Tavlasoglu M; Durukan E; Ucar Hİ; Yorgancioglu C
J Cardiothorac Surg; 2013 Apr; 8():71. PubMed ID: 23566712
[TBL] [Abstract][Full Text] [Related]
12. The simplified modification of diet in renal disease equation as a predictor of renal function after coronary artery bypass graft surgery.
Swart MJ; Bekker AM; Malan JJ; Meiring A; Swart Z; Joubert G
Cardiovasc J Afr; 2010; 21(1):9-12. PubMed ID: 20224838
[TBL] [Abstract][Full Text] [Related]
13. Impact of perioperative administration of 6 % hydroxyethyl starch 130/0.4 on serum cystatin C-derived renal function after radical prostatectomy: a single-centre retrospective study.
Südfeld S; Leyh-Bannurah SR; Budäus L; Graefen M; Reese PC; von Breunig F; Reuter DA; Saugel B
BMC Anesthesiol; 2016 Aug; 16(1):69. PubMed ID: 27576693
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Acute Kidney Injury and Blood Product Transfusion After Synthetic Colloid Use During Cardiac Surgery.
Tobey R; Cheng H; Gao M; Li Z; Young JN; Boyd WD; Ji F; Liu H
J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):853-862. PubMed ID: 28302346
[TBL] [Abstract][Full Text] [Related]
15. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?
Boks RH; Wijers MJ; Hofland J; Takkenberg JJ; Bogers AJ
Perfusion; 2007 Sep; 22(5):333-7. PubMed ID: 18416219
[TBL] [Abstract][Full Text] [Related]
16. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
[TBL] [Abstract][Full Text] [Related]
17. Association between resistin level and renal function in patients undergoing coronary artery bypass graft surgery.
Gungor H; Kirilmaz B; Zorlu A; Oguz E; Ayik MF; Kumak F; Zoghi M
J Investig Med; 2012 Aug; 60(6):883-7. PubMed ID: 22534631
[TBL] [Abstract][Full Text] [Related]
18. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements.
Hans GA; Ledoux D; Roediger L; Hubert MB; Koch JN; Senard M
J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):328-32. PubMed ID: 25440623
[TBL] [Abstract][Full Text] [Related]
19. Albumin utilization in cardiac surgery after transition to hydroxyethyl starch 130/0.4.
Romerill DB; Toyoda AY; Brodeur BE; Moellentin D
J Pharm Pract; 2012 Dec; 25(6):606-10. PubMed ID: 22797837
[TBL] [Abstract][Full Text] [Related]
20. Long-term Impact of Crystalloid versus Colloid Solutions on Renal Function and Disability-free Survival after Major Abdominal Surgery.
Joosten A; Delaporte A; Mortier J; Ickx B; Van Obbergh L; Vincent JL; Cannesson M; Rinehart J; Van der Linden P
Anesthesiology; 2019 Feb; 130(2):227-236. PubMed ID: 30418217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
